source
- Drug makers and animal testing groups urge FDA to keep flexible guidance on animal studies for cancer drugsA coalition of drug developers, regulators and laboratory animal-testing organizations has asked the U.S. Food and Drug Administration to keep its guidance on cancer-drug safety studies flexible.…
- CytoDyn’s leronlimab reaffirms HIV potential after combo treatment eradicates virus in infant macaquesCytoDyn's leronlimab may have struggled to secure approval as an HIV treatment, but research in infant primates has offered fresh hope for the CCR5-targeting antibody's ability to treat the virus.Fierce Biotech · 15h ago↗ source